Merit Medical Systems, Inc. (NASDAQ:MMSI) Receives Consensus Recommendation of “Moderate Buy” from Brokerages

Shares of Merit Medical Systems, Inc. (NASDAQ:MMSI) have received an average rating of “Moderate Buy” from the twelve analysts that are presently covering the company, MarketBeat Ratings reports. Three analysts have rated the stock with a hold rating, eight have issued a buy rating and one has issued a strong buy rating on the company. The average 12-month price target among brokers that have issued ratings on the stock in the last year is $100.00.

MMSI has been the subject of several analyst reports. Weiss Ratings upgraded shares of Merit Medical Systems from a “hold (c-)” rating to a “hold (c)” rating in a report on Tuesday, August 18th. Piper Sandler raised their target price on Merit Medical Systems from $96.00 to $106.00 and gave the stock an “overweight” rating in a research report on Friday, July 31st. Zacks Research upgraded Merit Medical Systems from a “hold” rating to a “strong-buy” rating in a research note on Tuesday, August 25th. BTIG Research reaffirmed a “buy” rating and issued a $105.00 price target on shares of Merit Medical Systems in a report on Tuesday, August 11th. Finally, Needham & Company LLC reiterated a “buy” rating and issued a $101.00 price target on shares of Merit Medical Systems in a research note on Tuesday, September 29th.

Institutional Inflows and Outflows

Large investors have recently modified their holdings of the stock. Conestoga Capital Advisors LLC lifted its position in Merit Medical Systems by 3.9% in the first quarter. Conestoga Capital Advisors LLC now owns 2,167,513 shares of the medical instruments supplier’s stock valued at $149,407,000 after acquiring an additional 81,030 shares during the last quarter. Dimensional Fund Advisors LP grew its holdings in shares of Merit Medical Systems by 1.0% during the first quarter. Dimensional Fund Advisors LP now owns 1,237,298 shares of the medical instruments supplier’s stock worth $85,287,000 after purchasing an additional 12,285 shares during the last quarter. William Blair Investment Management LLC purchased a new position in shares of Merit Medical Systems during the second quarter worth about $78,894,000. Norges Bank acquired a new stake in shares of Merit Medical Systems during the fourth quarter worth about $75,957,000. Finally, Maverick Capital Ltd. increased its position in shares of Merit Medical Systems by 46.9% during the first quarter. Maverick Capital Ltd. now owns 714,081 shares of the medical instruments supplier’s stock worth $49,222,000 after purchasing an additional 227,915 shares in the last quarter. Institutional investors and hedge funds own 99.66% of the company’s stock.

Merit Medical Systems Trading Down 0.9%

MMSI opened at $85.37 on Friday. Merit Medical Systems has a 12 month low of $59.74 and a 12 month high of $94.75. The stock has a market capitalization of $5.10 billion, a price-to-earnings ratio of 35.28, a PEG ratio of 2.13 and a beta of 0.51. The company has a debt-to-equity ratio of 0.44, a current ratio of 4.20 and a quick ratio of 2.79. The business has a fifty day moving average price of $87.61 and a 200 day moving average price of $74.65.

Merit Medical Systems (NASDAQ:MMSI) last issued its quarterly earnings results on Thursday, July 30th. The medical instruments supplier reported $1.19 earnings per share for the quarter, topping the consensus estimate of $0.96 by $0.23. The company had revenue of $418.84 million for the quarter, compared to the consensus estimate of $405.25 million. Merit Medical Systems had a return on equity of 13.75% and a net margin of 9.22%.Merit Medical Systems’s revenue was up 9.5% on a year-over-year basis. During the same quarter in the prior year, the business earned $1.01 EPS. Merit Medical Systems has set its FY 2026 guidance at 4.250-4.350 EPS. Sell-side analysts expect that Merit Medical Systems will post 3.84 earnings per share for the current fiscal year.

About Merit Medical Systems

Merit Medical Systems, Inc is a medical device company that develops, manufactures and markets disposable products used in interventional, diagnostic and therapeutic procedures. Its devices are designed for use by healthcare professionals in areas including cardiology, radiology, oncology, vascular intervention, gastroenterology and other specialty fields.

The company’s product portfolio includes devices for accessing the vasculature, controlling and managing fluids, performing biopsies, treating peripheral vascular disease, delivering embolic therapies, and supporting drainage and intervention procedures.